ArticleHuman vaccines & immunotherapeutics2012

Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNA.

Thomas L Richie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.